These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10611763)

  • 1. Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases.
    Chen W; Wahl SM
    Microbes Infect; 1999 Dec; 1(15):1367-80. PubMed ID: 10611763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
    Prud'homme GJ; Piccirillo CA
    J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Kriegel MA; Li MO; Sanjabi S; Wan YY; Flavell RA
    Curr Rheumatol Rep; 2006 Apr; 8(2):138-44. PubMed ID: 16569373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic effects of transforming growth factor-beta on cells of the immune system.
    Ruscetti F; Varesio L; Ochoa A; Ortaldo J
    Ann N Y Acad Sci; 1993 Jun; 685():488-500. PubMed ID: 8363258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model.
    Song XY; Gu M; Jin WW; Klinman DM; Wahl SM
    J Clin Invest; 1998 Jun; 101(12):2615-21. PubMed ID: 9637694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of immune responses by TGF-beta.
    Letterio JJ; Roberts AB
    Annu Rev Immunol; 1998; 16():137-61. PubMed ID: 9597127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis.
    Yotsukura J; Huang H; Singh AK; Shichi H
    Cell Immunol; 1997 Dec; 182(2):89-98. PubMed ID: 9514702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical applications of transforming growth factor-beta.
    Flanders KC; Burmester JK
    Clin Med Res; 2003 Jan; 1(1):13-20. PubMed ID: 15931280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation.
    Strober W; Kelsall B; Fuss I; Marth T; Ludviksson B; Ehrhardt R; Neurath M
    Immunol Today; 1997 Feb; 18(2):61-4. PubMed ID: 9057354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta (TGF-beta) and autoimmunity.
    Aoki CA; Borchers AT; Li M; Flavell RA; Bowlus CL; Ansari AA; Gershwin ME
    Autoimmun Rev; 2005 Sep; 4(7):450-9. PubMed ID: 16137611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
    Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
    Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous activation of transforming growth factor-beta gene transcription in broncho-alveolar mononuclear cells of individuals with systemic autoimmune diseases with lung involvement.
    Deguchi Y; Kishimoto S
    Lupus; 1991 Nov; 1(1):27-30. PubMed ID: 1845359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines in kidney disease: the role of transforming growth factor-beta.
    Border WA; Noble NA
    Am J Kidney Dis; 1993 Jul; 22(1):105-13. PubMed ID: 8322771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated.
    Diebold RJ; Eis MJ; Yin M; Ormsby I; Boivin GP; Darrow BJ; Saffitz JE; Doetschman T
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12215-9. PubMed ID: 8618872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of bacterial cell wall-induced leukocyte recruitment and hepatic granuloma formation by TGF-beta gene transfer.
    Song X; Zeng L; Pilo CM; Zagorski J; Wahl SM
    J Immunol; 1999 Oct; 163(7):4020-6. PubMed ID: 10491005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of scleroderma. Collagen.
    Jimenez SA; Hitraya E; Varga J
    Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor-beta 1.
    Qin L; Chavin KD; Ding Y; Woodward JE; Favaro JP; Lin J; Bromberg JS
    Ann Surg; 1994 Oct; 220(4):508-18; discussion 518-9. PubMed ID: 7944661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis.
    Ohta K; Wiggert B; Yamagami S; Taylor AW; Streilein JW
    J Immunol; 2000 Feb; 164(3):1185-92. PubMed ID: 10640729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.